quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:32·3d
SECFiling
BrainsWay Ltd. logo

SEC Form 20-F filed by BrainsWay Ltd.

BWAY· BrainsWay Ltd.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • BWAY
    BrainsWay Ltd.
    Health Care

Recent analyst ratings

  • Nov 16UpdateRaymond James-
  • Mar 3UpdateLoop Capital$15.00
  • Nov 29UpdateHC Wainwright & Co.$15.00
  • Aug 12UpdateHC Wainwright & Co.$14.00
  • Jul 19UpdateHC Wainwright & Co.$17.00

Related

  • SEC3d
    SEC Form S-8 filed by BrainsWay Ltd.
  • SEC3d
    SEC Form S-8 POS filed by BrainsWay Ltd.
  • SEC8d
    SEC Form 6-K filed by BrainsWay Ltd.
  • PR8d
    BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy
  • PR10d
    BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference
  • SEC17d
    SEC Form SCHEDULE 13G filed by BrainsWay Ltd.
  • SEC28d
    SEC Form 6-K filed by BrainsWay Ltd.
  • PR28d
    BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022